Old Web
English
Sign In
Acemap
>
authorDetail
>
Brigitte Bosman
Brigitte Bosman
Astellas Pharma
Urology
Medicine
Overactive bladder
Internal medicine
Solifenacin
3
Papers
6
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Relationship between mean volume voided and incontinence in children with overactive bladder treated with solifenacin: post hoc analysis of a phase 3 randomised clinical trial.
2020
European Journal of Pediatrics
Robert Snijder
Brigitte Bosman
Otto Stroosma
Marja Agema
Show All
Source
Cite
Save
Citations (0)
Long-term efficacy and safety of solifenacin in pediatric patients aged 6 months to 18 years with neurogenic detrusor overactivity: results from two phase 3 prospective open-label studies
2019
Journal of Pediatric Urology
Israel Franco
Piet Hoebeke
Malgorzata Baka-Ostrowska
David Bolong
Leon N. Davies
Ellen Dahler
Robert Snijder
Otto Stroosma
Frank Verheggen
Donald Newgreen
Brigitte Bosman
Johan Vande Walle
Show All
Source
Cite
Save
Citations (3)
The pharmacokinetics, safety, and tolerability of mirabegron in children and adolescents with neurogenic detrusor overactivity or idiopathic overactive bladder and development of a population pharmacokinetic model-based pediatric dose estimation
2019
Journal of Pediatric Urology
Søren Rittig
Malgorzata Baka-Ostrowska
Camilla Tøndel
Johan Vande Walle
Birgitta Kjaeer
Paul Passier
Brigitte Bosman
Otto Stroosma
Stacey Tannenbaum
Show All
Source
Cite
Save
Citations (3)
1